Lemtrada Patients Report Positive Experiences From Taking The Anti-MS Drug

Lemtrada Stroke Lawsuit News

A person has to know what multiple sclerosis patients go through to understand why they would risk their lives by taking the drug Lemtrada

Tuesday, February 4, 2020 - Lemtrada, manufactured by Sanofi Inc., is a disease-modifying therapy administered by intravenous infusion to treat Relapsing-Remitting Multiple Sclerosis and was approved by the FDA in 2014. Lemtrada is highly restricted by the FDA and Europe's Medical Agency because it can cause arterial dissection, leading to a stroke within 24-72 hours after the intravenous infusions begin. The drug can only be prescribed as a last resort after two or more other anti-RRMS drugs have been tried and failed and the drug can only be administered to a patient under the supervision of emergency room staff in case the patient has a stroke, heart attack, or other serious response. Multiple Sclerosis.net interviewed a Lemtrada patient and asked questions about a woman's experience on the drug. Lemtrada attorneys are helping families and individuals that are suffering from MS and were exposed to arterial dissection and stroke since 2014, with no warnings and offer a free consultation before filing a lawsuit claim.

The woman who remained anonymous was diagnosed with relapse remitting multiple sclerosis (RRMS) after suffering for years with Lupus. The patient's condition had deteriorated to critical and she suffered from "having to use a wheelchair, slurred speech, loss of bladder and bowel control, cognitive disorder, severe pain, and muscle spasms." The woman's disease had entered the primary progressive stage and her doctor told her that there was no drug to treat her. The patient experienced lesions on her neck and at the base of her brain. A British doctor reviewing her case suggested that she try Lemtrada, a then-new and unproven, yet promising anti-RRMS drug that was having success in Europe.

The woman's Lemtrada treatment started in 2006 and lasted 5 hours per day over three days. Lemtrada treatments are administered only once per year for three years with an option for years four and five. The woman dealt with the general side effects of the drug but according to her were worth it because of the "amazing" results she experienced. "After the third dose, I was out of the wheelchair and a lot of my symptoms had reversed themselves. Even my lesions had disappeared on my MRI's. It was my Miracle Drug," the patient explained. The patients walked up to 4 miles per day without assistance and contemplated going back to work. After the third year, her symptoms began to return, however, and she opted to restart treatment for years 4 and 5.

Today, Lemtrada patients' primary fear is having a stroke within 24 - 72 hours of their first treatment. According to Lemtrada.com, Lemtrada's most dangerous symptoms are "Stroke and tears in your arteries that supply blood to your brain (carotid and vertebral arteries): Some people have had serious and sometimes deadly strokes and tears in their carotid or vertebral arteries within 3 days of receiving LEMTRADA. "

The following are signs that you could be about to have a stroke and to immediately seek medical help: "drooping of parts of your face, weakness on one side, sudden severe headache, difficulty with speech, and neck pain."

More Recent Lemtrada Stroke Lawsuit News:

No-Cost, No-Obligation Lemtrada Lawsuit Case Review If You or a Loved One Suffered from Lemtrada Stroke Complications

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.